Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | GFH276 |
| Trade Name | |
| Synonyms | GFH 276|GFH-276 |
| Drug Descriptions |
GFH276 is a panRAS(ON) inhibitor, which potentially inhibits growth of RAS-mutant tumors (Cancer Res (2026) 86 (7_Supplement): 4565). |
| DrugClasses | RAS Inhibitor (Pan) 15 |
| CAS Registry Number | NA |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Cetuximab + GFH276 | Cetuximab GFH276 | 0 | 0 |
| Fluorouracil + GFH276 + Irinotecan + Leucovorin + Oxaliplatin | Fluorouracil GFH276 Irinotecan Leucovorin Oxaliplatin | 0 | 0 |
| Gemcitabine + GFH276 + Nab-paclitaxel | GFH276 Gemcitabine Nab-paclitaxel | 0 | 0 |
| GFH276 | GFH276 | 0 | 0 |